JR-141: Clinical Trials

7 trials of JR-141, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 3 completed, 1 enrolling by invitation. 5 Phase 2, 4 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Active not recruiting 2
Phase 34Active not recruiting 2, Completed 1, Enrolling by invitation 1
Phase 11Completed 1

Follow JR-141: new trials by email Literature Review of JR-141 trials Research Report on JR-141

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II (Hunter Syndrome) Subjects
JR-141 - Mucopolysaccharidosis II
Phase 3Enrolling by invitationJCR Pharmaceuticals Co., Ltd.802023-02-222026-01-21
A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)
JR-141, Idursulfase, JR-141 or Idursulfase - Mucopolysaccharidosis II
Phase 3Active not recruitingJCR Pharmaceuticals Co., Ltd.862022-02-142026-10-02
An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II
JR-141 - Mucopolysaccharidosis II
Phase 2 / Phase 3Active not recruitingJCR Pharmaceuticals Co., Ltd.272019-09-012026-09-03
An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II
JR-141 - Mucopolysaccharidosis II
Phase 2Active not recruitingJCR Pharmaceuticals Co., Ltd.192019-01-012026-09-08
A Study of JR-141 in Patients With Mucopolysaccharidosis II
JR-141 - Mucopolysaccharidosis II
Phase 2 / Phase 3CompletedJCR Pharmaceuticals Co., Ltd.282018-08-012022-11-14
A Study of JR-141 in Patients With Mucopolysaccharidosis II (BR21)
JR-141 - Mucopolysaccharidosis II
Phase 2CompletedJCR Pharmaceuticals Co., Ltd.182018-07-262025-07-24
A Study of JR-141 in Patients With Mucopolysaccharidosis Type II
JR-141 - Mucopolysaccharidosis II
Phase 1 / Phase 2CompletedJCR Pharmaceuticals Co., Ltd.142017-03-302022-11-14

Conditions studied

Mucopolysaccharidosis II (7)

Sponsors

JCR Pharmaceuticals Co., Ltd. (7)

Countries

Brazil (4)  ·  Japan (3)  ·  Argentina (2)  ·  France (2)  ·  Germany (2)  ·  Italy (2)  ·  Poland (2)  ·  Spain (2)  ·  United States (2)  ·  Colombia (1)  ·  Israel (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Results publications

PMID 30595526